Handelsbanken Fonder AB - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 214 filers reported holding PTC THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
Handelsbanken Fonder AB ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$679
-14.5%
22,200
-18.7%
0.00%0.0%
Q1 2024$794
+72.6%
27,300
+63.5%
0.00%
+50.0%
Q4 2023$460
+54.4%
16,700
+25.6%
0.00%0.0%
Q3 2023$298
-95.2%
13,300
-91.3%
0.00%
-93.9%
Q2 2023$6,235
-33.0%
153,300
-20.2%
0.03%
-38.9%
Q1 2023$9,300
+4.1%
192,000
-17.9%
0.05%
-3.6%
Q4 2022$8,932
-100.0%
234,000
-53.7%
0.06%
-67.1%
Q3 2022$25,371,000
+21.7%
505,400
-2.9%
0.17%
+25.9%
Q2 2022$20,847,000
+47.4%
520,400
+37.3%
0.14%
+70.9%
Q1 2022$14,140,000
-4.9%
379,000
+1.6%
0.08%
+8.2%
Q4 2021$14,861,000
+7.0%
373,1000.0%0.07%0.0%
Q3 2021$13,883,000
-11.7%
373,100
+0.3%
0.07%
-11.0%
Q2 2021$15,729,000
-10.4%
372,100
+0.4%
0.08%
-18.0%
Q1 2021$17,557,000
-21.4%
370,800
+1.4%
0.10%
-26.5%
Q4 2020$22,325,000
+26.7%
365,800
-2.9%
0.14%
+5.4%
Q3 2020$17,615,000
-50.7%
376,800
-46.4%
0.13%
-15.1%
Q2 2020$35,700,000
+148.5%
703,600
+118.5%
0.15%
-50.8%
Q1 2020$14,364,000
-21.9%
322,000
-15.9%
0.31%
-2.8%
Q4 2019$18,395,000
+68.4%
383,000
+18.6%
0.32%
+43.9%
Q3 2019$10,924,000
-10.1%
323,000
+19.6%
0.22%
-1.8%
Q2 2019$12,150,000270,0000.22%
Other shareholders
PTC THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Asymmetry Capital Management, L.P. 110,794$3,802,00010.50%
Boxer Capital, LLC 2,155,000$73,960,0009.14%
RTW INVESTMENTS, LP 1,922,346$65,975,0006.14%
GREAT POINT PARTNERS LLC 1,225,000$42,042,0005.31%
Opaleye Management Inc. 190,000$6,520,0002.43%
SCOPIA CAPITAL MANAGEMENT LP 1,626,965$55,837,0001.89%
SPHERA FUNDS MANAGEMENT LTD. 345,500$11,858,0001.34%
SECTORAL ASSET MANAGEMENT INC 233,536$8,015,0001.09%
Elk Creek Partners, LLC 377,674$12,962,0001.08%
Orbimed Advisors 1,519,700$52,156,0000.96%
View complete list of PTC THERAPEUTICS INC shareholders